Astrocytoma medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 33: Line 33:
** Proton beam [[radiation therapy]] is a type of high-energy, external [[radiation therapy]] that uses streams of [[proton]]s (small, positively-charged particles of matter) to kill [[tumor]] cells.
** Proton beam [[radiation therapy]] is a type of high-energy, external [[radiation therapy]] that uses streams of [[proton]]s (small, positively-charged particles of matter) to kill [[tumor]] cells.
* For children younger than 3 years, [[chemotherapy]] may be given instead, to delay or reduce the need for [[radiation therapy]].<ref name=NCI>{{cite web | title = National Caner Institute Astrocytoma| url =http://www.cancer.gov/types/brain/hp/child-astrocytoma-treament-pdq#cit/section_1.19 }}</ref>
* For children younger than 3 years, [[chemotherapy]] may be given instead, to delay or reduce the need for [[radiation therapy]].<ref name=NCI>{{cite web | title = National Caner Institute Astrocytoma| url =http://www.cancer.gov/types/brain/hp/child-astrocytoma-treament-pdq#cit/section_1.19 }}</ref>
==Treatment Options for Childhood Astrocytomas==
===Newly Diagnosed Childhood Low-Grade Astrocytomas===
When the tumor is first diagnosed, treatment for childhood low-grade astrocytomadepends where the tumor is, and is usually surgery. An MRI is done after surgery to see if there is tumor remaining.
If the tumor was completely removed by surgery, more treatment may not be needed and the child is closely watched to see if signs or symptoms appear or change. This is calledobservation.
If there is tumor remaining after surgery, treatment may include the following:
Observation.
A second surgery to remove the tumor.
Radiation therapy, which may include conformal radiation therapy, intensity-modulated radiation therapy, or stereotactic radiation therapy, when the tumor begins to grow again.
Combination chemotherapy with or without radiation therapy.
A clinical trial of targeted therapy with selumetinib.
In some cases, observation is used for children who have a visual pathway glioma. In other cases, treatment may include surgery to remove the tumor, radiation therapy, orchemotherapy. A goal of treatment is to save as much vision as possible. The effect of tumor growth on the child's vision will be closely followed during treatment.
Children with neurofibromatosis type 1 (NF1) may not need treatment unless the tumor grows or signs or symptoms, such as vision problems, appear. When the tumor grows or signs or symptoms appear, treatment may include surgery to remove the tumor, radiation therapy, and/or chemotherapy.
Children with tuberous sclerosis may develop benign (not cancer) tumors in the brain called subependymal giant cell astrocytomas (SEGAs). Targeted therapy with everolimus orsirolimus may be used instead of surgery, to shrink the tumors.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with childhood low-grade untreated astrocytoma or other tumor of glial origin. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your child's doctor about clinical trials that may be right for your child. General information about clinical trials is available from the NCI Web site.
Recurrent Childhood Low-Grade Astrocytomas
Before more cancer treatment is given, imaging tests, biopsy, or surgery are done to find out if there is cancer and how much there is.
Treatment of recurrent childhood low-grade astrocytoma may include the following:
A second surgery to remove the tumor, if surgery was the only treatment given when the tumor was first diagnosed.
Radiation therapy to the tumor only, if radiation therapy was not used when the tumor was first diagnosed. Conformal radiation therapy may be given.
Chemotherapy, if the tumor recurred where it cannot be removed by surgery or the patient had radiation therapy when the tumor was first diagnosed.
Chemotherapy and targeted therapy with bevacizumab.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with recurrent childhood astrocytoma or other tumor of glial origin. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your child's doctor about clinical trials that may be right for your child. General information about clinical trials is available from the NCI Web site.
Newly Diagnosed Childhood High-Grade Astrocytomas
Treatment of childhood high-grade astrocytoma may include the following:
Surgery to remove the tumor, followed by chemotherapy and radiation therapy.
A clinical trial of chemotherapy with or without radiation therapy.
A clinical trial of a new treatment.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with childhood high-grade untreated astrocytoma or other tumor of glial origin. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your child's doctor about clinical trials that may be right for your child. General information about clinical trials is available from the NCI Web site.
Recurrent Childhood High-Grade Astrocytomas
Before more cancer treatment is given, imaging tests, biopsy, or surgery are done find out if there is cancer and how much there is.
Treatment of recurrent childhood high-grade astrocytoma may include the following:
Surgery.
High-dose chemotherapy with stem cell transplant.
A clinical trial of a new treatment.
A clinical trial of targeted therapy with dabrafenib.
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with recurrent childhood astrocytoma or other tumor of glial origin. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your child's doctor about clinical trials that may be right for your child. General information about clinical trials is available from the NCI Web site.
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 15:39, 24 August 2015

Astrocytoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Astrocytoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Study

Case #1

Astrocytoma medical therapy On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Astrocytoma medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Astrocytoma medical therapy

CDC on Astrocytoma medical therapy

Astrocytoma medical therapy in the news

Blogs on Astrocytoma medical therapy

Directions to Hospitals Treating Astrocytoma

Risk calculators and risk factors for Astrocytoma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

The optimal therapy of astrocytoma depends on the stage of diagnosis. Chemotherapy is recommended for children. Radiation and chemotherpy with stem cell transplant is recommended for adults with high grade astrocytoma.

Medical Therapy

Chemotherapy

High-dose chemotherapy with stem cell transplant

  • Rapamycin showed efficacy in five cases of SEGA in TSC patients, shrinking their tumor volumes by an average of 65%. However, after the drug was stopped, the tumors regrew.
  • Everolimus which has a similar structure as rapamycin, but with slightly increased bioavailability and shorter half-life, was studied in 28 patients with SEGA. There was a significant reduction in SEGA size in 75% of the patients, and a mild improvement in their seizures. Everolimus was approved for the treatment of SEGA by the US Food and Drug Administration (FDA) in October, 2010.
  • Medicines used to treat primary brain tumors in children include:
  • Comfort measures, safety measures, physical therapy, occupational therapy, and other such steps may be required to improve quality of life.
  • Despite decades of therapeutic research, curative intervention is still nonexistent for high grade astrocytomas; patient care ultimately focuses on palliative management.

Radiation Therapy

Treatment Options for Childhood Astrocytomas

Newly Diagnosed Childhood Low-Grade Astrocytomas

When the tumor is first diagnosed, treatment for childhood low-grade astrocytomadepends where the tumor is, and is usually surgery. An MRI is done after surgery to see if there is tumor remaining.

If the tumor was completely removed by surgery, more treatment may not be needed and the child is closely watched to see if signs or symptoms appear or change. This is calledobservation.

If there is tumor remaining after surgery, treatment may include the following:

Observation. A second surgery to remove the tumor. Radiation therapy, which may include conformal radiation therapy, intensity-modulated radiation therapy, or stereotactic radiation therapy, when the tumor begins to grow again. Combination chemotherapy with or without radiation therapy. A clinical trial of targeted therapy with selumetinib.

In some cases, observation is used for children who have a visual pathway glioma. In other cases, treatment may include surgery to remove the tumor, radiation therapy, orchemotherapy. A goal of treatment is to save as much vision as possible. The effect of tumor growth on the child's vision will be closely followed during treatment.

Children with neurofibromatosis type 1 (NF1) may not need treatment unless the tumor grows or signs or symptoms, such as vision problems, appear. When the tumor grows or signs or symptoms appear, treatment may include surgery to remove the tumor, radiation therapy, and/or chemotherapy.

Children with tuberous sclerosis may develop benign (not cancer) tumors in the brain called subependymal giant cell astrocytomas (SEGAs). Targeted therapy with everolimus orsirolimus may be used instead of surgery, to shrink the tumors.

Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with childhood low-grade untreated astrocytoma or other tumor of glial origin. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your child's doctor about clinical trials that may be right for your child. General information about clinical trials is available from the NCI Web site.

Recurrent Childhood Low-Grade Astrocytomas

Before more cancer treatment is given, imaging tests, biopsy, or surgery are done to find out if there is cancer and how much there is.

Treatment of recurrent childhood low-grade astrocytoma may include the following:

A second surgery to remove the tumor, if surgery was the only treatment given when the tumor was first diagnosed. Radiation therapy to the tumor only, if radiation therapy was not used when the tumor was first diagnosed. Conformal radiation therapy may be given. Chemotherapy, if the tumor recurred where it cannot be removed by surgery or the patient had radiation therapy when the tumor was first diagnosed. Chemotherapy and targeted therapy with bevacizumab.

Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with recurrent childhood astrocytoma or other tumor of glial origin. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your child's doctor about clinical trials that may be right for your child. General information about clinical trials is available from the NCI Web site.

Newly Diagnosed Childhood High-Grade Astrocytomas

Treatment of childhood high-grade astrocytoma may include the following:

Surgery to remove the tumor, followed by chemotherapy and radiation therapy. A clinical trial of chemotherapy with or without radiation therapy. A clinical trial of a new treatment.

Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with childhood high-grade untreated astrocytoma or other tumor of glial origin. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your child's doctor about clinical trials that may be right for your child. General information about clinical trials is available from the NCI Web site.

Recurrent Childhood High-Grade Astrocytomas

Before more cancer treatment is given, imaging tests, biopsy, or surgery are done find out if there is cancer and how much there is.

Treatment of recurrent childhood high-grade astrocytoma may include the following:

Surgery. High-dose chemotherapy with stem cell transplant. A clinical trial of a new treatment. A clinical trial of targeted therapy with dabrafenib.

Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with recurrent childhood astrocytoma or other tumor of glial origin. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your child's doctor about clinical trials that may be right for your child. General information about clinical trials is available from the NCI Web site.

References

  1. "National Caner Institute Astrocytoma".

Template:WH Template:WS